<?xml version="1.0" encoding="UTF-8"?>
<ref id="B178">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Urakami</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ngwe Tun</surname>
    <given-names>M. M.</given-names>
   </name>
   <name>
    <surname>Moi</surname>
    <given-names>M. L.</given-names>
   </name>
   <name>
    <surname>Sakurai</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ishikawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kuno</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>An envelope-modified tetravalent dengue virus-like-particle vaccine has implications for flavivirus vaccine design.</article-title>
  <source>
   <italic>J. Virol.</italic>
  </source>
  <volume>91</volume>:
  <issue>e01181-17</issue>. 
  <pub-id pub-id-type="doi">10.1128/JVI.01181-17</pub-id>
  <?supplied-pmid 28956764?>
  <pub-id pub-id-type="pmid">28956764</pub-id>
 </mixed-citation>
</ref>
